Pyxis Oncology, Inc. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at approximately $50 million (effective 2024-02-26).
“On February 26, 2024, Pyxis Oncology, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) for a private placement (the “Private Placement”) with certain institutional and accredited investors (each, a “Purchaser” and collectively, the “Purchasers”).”
LYFTLyft, Inc.
Lyft, Inc. entered into Purchase Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers valued at $400 million aggregate principal amount (effective 2024-02-22).
“On February 22, 2024, Lyft, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers (the “Initial Purchasers”), to issue and sell $400 million aggregate principal amount of its 0.625% Convertible Senior Notes due 2029 (the “Base Notes”).”
BKSYBlackSky Technology Inc.
BlackSky Technology Inc. entered into Lease with 2411 Dulles Corner Metro Owner LLC (effective 2023-11-20).
“BlackSky Holdings, Inc. (the “Tenant”), a wholly-owned subsidiary of BlackSky Technology Inc. (the “Company”), entered into a lease agreement (the “Lease”) with 2411 Dulles Corner Metro Owner LLC, a Delaware limited liability company (the “Landlord”) on November 20, 2023”
GoLogiq, Inc.
GoLogiq, Inc. entered into GOLQ Licensing Agreement with Recruiter.com Group, Inc. valued at 19.99% of the number of issued and outstanding shares of Recruiter common stock (effective 2024-02-23).
“On February 23, 2024, the Company entered into a certain Technology License and Commercialization Agreement with Recruiter (the “GOLQ Licensing Agreement”)”
NRXPNRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. entered into Underwriting Agreement with EF Hutton LLC (effective 2024-02-27).
“On February 27, 2024, NRx Pharmaceuticals, Inc. (the " Company ") entered into an underwriting agreement (the " Underwriting Agreement ") with EF Hutton LLC (the " Representative "), as the representative of the several underwriters named therein (the " Underwriters "), relating to an underwritten public offering (the " Offering ") of 5,000,000 shares (the " Shares ") of the Company’s common stock, par value $0.001 per share (" Common Stock ").”
Southern States Bancshares, Inc.
Southern States Bancshares, Inc. entered into Agreement and Plan of Merger with CBB Bancorp (effective 2024-02-27).
“On February 27, 2024, Southern States Bancshares, Inc. (“Southern States Bancshares”), the parent company of Southern States Bank (“Southern States Bank”), and CBB Bancorp (“CBB Bancorp”), the parent company of Century Bank of Georgia (“Century Bank”), entered into an Agreement and Plan of Merger (the “Agreement”)”
ABSIAbsci Corp
Absci Corp entered into Underwriting Agreement with Morgan Stanley & Co. LLC and Cowen & Company, LLC valued at public offering price of $4.50 per share (effective 2024-02-27).
“On February 27, 2024, Absci Corporation (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Morgan Stanley & Co. LLC and Cowen & Company, LLC (the “ Underwriters ”), relating to the issuance and sale of an aggregate of 16,700,000 shares (the “ Underwritten Shares ”) of the Company’s common stock”
CLPRClipper Realty Inc.
Clipper Realty Inc. terminated Lease with The City of New York valued at $15.4 million per annum (effective 2025-08-23).
“Clipper Realty Inc, (the “Company”), through its subsidiary 250 Livingston Owner LLC (“250 Livingston Owner”), leases to The City of New York, a municipal corporation acting through the Department of Citywide Administrative Services (“NYC”), 342,496 square feet of office space located at 240-250 Livingston Street, Brooklyn, NY (the “Building”), pursuant to a lease agreement dated as of May 8, 2019 (the “Lease”).”
VTVTvTv Therapeutics Inc.
vTv Therapeutics Inc. amended G42 Amendment with G42 Investments AI Holdings RSC Ltd (effective 2024-02-27).
“the Company entered into an amendment to the Common Stock Purchase Agreement with G42 Investments AI Holdings RSC Ltd (“G42”) (the “G42 Amendment”), on February 27, 2024”
VTVTvTv Therapeutics Inc.
vTv Therapeutics Inc. entered into Registration Rights Agreement with the Purchasers (effective 2024-02-27).
“On February 27, 2024, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, pursuant to which the Company agreed to register for resale the Shares and the Warrant Shares held by the Purchasers”
VTVTvTv Therapeutics Inc.
vTv Therapeutics Inc. entered into Securities Purchase Agreement with certain institutional accredited investors valued at aggregate gross proceeds of approximately $51.0 million (effective 2024-02-27).
“On February 27, 2024, vTv Therapeutics Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional accredited investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”) (i) an aggregate of 464,377 shares (the “Shares”) of the Company’s Class A common stock, par value $0.01 per share (the “Common Stock”), at a purchase price of $11.81 per share, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 3,853,997 shares of Common Stock (the “Warrant Shares”) at a purchase price of $11.80 per Pre-Funded Warrant”
VTVTvTv Therapeutics Inc.
vTv Therapeutics Inc. entered into Sales Agreement with Cowen and Company, LLC valued at up to $50.0 million (effective 2024-02-28).
“On February 28, 2024, vTv Therapeutics Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Cowen and Company, LLC (“TD Cowen”), pursuant to which the Company may offer and sell, from time to time, through TD Cowen, as sales agent, shares of the Company’s Class A common stock, par value $0.01 per share, having an aggregate offering price of up to $50.0 million (the “ATM Offering”).”
Tri-State Generation & Transmission Association, Inc.
Tri-State Generation & Transmission Association, Inc. terminated Wholesale Electric Service Contract with Northwest Rural Public Power District (effective 2024-05-01).
“certain specified contracts between Tri‐State and NRPPD, including the Wholesale Electric Service Contract, dated July 1, 2007, (“WESC”) will terminate”
Tri-State Generation & Transmission Association, Inc.
Tri-State Generation & Transmission Association, Inc. entered into Membership Withdrawal Agreement with Northwest Rural Public Power District.
“On February 27, 2 024, Tri-State filed with FERC an unexecuted version of a Membership Withdrawal Agreement (“Withdrawal Agreement”), between Tri-State and NRPPD, in FERC Docket No. ER24-1341-000.”
JRVRJames River Group Holdings, Inc.
James River Group Holdings, Inc. amended BMO Facility with BMO Bank N.A. valued at Waived Event of Default under Section 7.01(d)(i) until March 1, 2025 due to A.M. Best downgrade of J (effective 2024-02-26).
“On February 26, 2024, James River Group Holdings, Ltd. (the “Company”) entered into (i) a Waiver Agreement to the Third Amended and Restated Credit Agreement dated as of July 7, 2023 (the “KeyBank Facility”) by and among the Company and JRG Reinsurance Company Ltd. (“JRG Re”), as borrowers, KeyBank National Association (“KeyBank”) as Administrative Agent and Letter of Credit Issuer, KeyBank and Truist Securities, Inc. as Joint Book Runners and Joint Lead Arrangers, Truist Bank as Syndication Agent, and the lender parties thereto (the “KeyBank Lenders”) (the “KeyBank Waiver”), and (ii) a Limited Waiver Agreement to the Credit Agreement dated as of August 2, 2017, as amended, (the “BMO Facility”) by and among the Company and JRG Re, as borrowers, and BMO Bank N.A., as the lender (“BMO”) (together with the KeyBank Waiver, the “Waivers” and each a “Waiver”).”
JRVRJames River Group Holdings, Inc.
James River Group Holdings, Inc. amended KeyBank Facility with KeyBank National Association as Administrative Agent, KeyBank Lenders valued at Waived Event of Default under Section 7.01(d)(i) until March 1, 2025 due to A.M. Best downgrade of J (effective 2024-02-26).
“On February 26, 2024, James River Group Holdings, Ltd. (the “Company”) entered into (i) a Waiver Agreement to the Third Amended and Restated Credit Agreement dated as of July 7, 2023 (the “KeyBank Facility”) by and among the Company and JRG Reinsurance Company Ltd. (“JRG Re”), as borrowers, KeyBank National Association (“KeyBank”) as Administrative Agent and Letter of Credit Issuer, KeyBank and Truist Securities, Inc. as Joint Book Runners and Joint Lead Arrangers, Truist Bank as Syndication Agent, and the lender parties thereto (the “KeyBank Lenders”) (the “KeyBank Waiver”)”
Societal CDMO, Inc.
Societal CDMO, Inc. entered into Agreement and Plan of Merger with CoreRx, Inc. and Cane Merger Sub, Inc. (effective 2024-02-28).
“On February 28, 2024, Societal CDMO, Inc., a Pennsylvania corporation (the “Company” or “Societal”), CoreRx, Inc., a Florida corporation (“Parent” or “CoreRx”), and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned subsidiary of Parent (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”).”
Innoveren Scientific, Inc.
Innoveren Scientific, Inc. entered into Purchase Agreement with an accredited investor (effective 2024-02-23).
“On February 23, 2024, Innoveren Scientific, Inc. (the “Company”) entered into a securities purchase agreement with an accredited investor for the sale of shares of Common Stock and warrants (the “Purchase Agreement”).”
Energy 11, L.P.
Energy 11, L.P. amended Fifth Amendment with BancFirst valued at $100,000 (effective 2024-03-01).
“On February 27, 2024, the Partnership and the Lender entered into an amendment (“Fifth Amendment”) to the BF Loan Agreement, effective March 1, 2024 (“Effective Date”), that renewed and extended the BF Credit Facility for two additional years to March 1, 2026 (“Revised Maturity Date”).”
PRKSUnited Parks & Resorts Inc.
United Parks & Resorts Inc. entered into First Amendment to Stockholders Agreement with Hill Path Capital LP valued at Amends voting and approval provisions; requires Special Committee and Disinterested Stockholder Appr (effective 2024-02-27).
“On February 27, 2024, United Parks & Resorts Inc. (the “Company”) and Hill Path Capital LP (“Hill Path”) entered into the First Amendment (the “Amendment”) to the Stockholders Agreement, dated as of May 27, 2019”
Independence Contract Drilling, Inc.
Independence Contract Drilling, Inc. amended Third Supplemental Indenture with U.S. Bank Trust Company National Association valued at Amends capital expenditure covenant for 2024 and 2025 (effective 2024-02-27).
“On February 27, 2024, Independence Contract Drilling, Inc. (the “Company”) entered into a Third Supplemental Indenture, dated February 27, 2024 (the “Third Supplemental Indenture), by and among the Company, the Guarantor party thereto, and U.S. Bank Trust Company National Association, as trustee (in such capacity, the “Trustee”) and as collateral agent (in such capacity, the “Collateral Agent”), to that certain Indenture, dated March 18, 2022 (as amended by the First Supplemental Indenture, dated July 21, 2022, and Second Supplemental Indenture dated February 24, 2023 the “Indenture”), relating to the Company’s Floating Rate Convertible Senior Secured PIK Toggle Notes due 2026.”
“The Credit Agreement is guaranteed by Phillips 66 and replaces the $5 billion Credit Agreement dated as of June 23, 2022 (the “Existing Credit Agreement”) with the Company as the borrower and Phillips 66 as guarantor.”
PSXPhillips 66
Phillips 66 entered into Credit Agreement with a syndicate of banks and other financial institutions party thereto and Mizuho Bank, Ltd. valued at $5 billion (effective 2024-02-28).
“On February 28, 2024, Phillips 66 Company (the “Company”), a wholly-owned subsidiary of Phillips 66, entered into a $5 billion revolving credit agreement with a syndicate of banks and other financial institutions party thereto and Mizuho Bank, Ltd., as administrative agent (the “Credit Agreement”).”
Plymouth Industrial REIT, Inc.
Plymouth Industrial REIT, Inc. terminated 2023 Distribution Agreement with the agents party thereto (effective 2024-02-27).
“Substantially concurrent with the Company’s and the Operating Partnership’s entry into the Distribution Agreement (as defined below), the Company has terminated its existing Distribution Agreement, dated as of February 28, 2023, among the Company, the Operating Partnership, and the agents party thereto (as amended, the “2023 Distribution Agreement”), in accordance with the terms of the 2023 Distribution Agreement.”
Plymouth Industrial REIT, Inc.
Plymouth Industrial REIT, Inc. entered into Distribution Agreement with KeyBanc Capital Markets Inc., Robert W. Baird & Co. Incorporated, Barclays Capital Inc., Berenberg Capital Markets, LLC, BMO Capital Markets Corp., B. Riley Securities, Inc., Capital One Securities, Inc., Colliers Securities LLC, Citizens JMP Securities, LLC, Scotia Capital (USA) Inc., Truist Securi valued at $200 million (effective 2024-02-27).
“On February 27, 2024, the Company and the Operating Partnership entered into a Distribution Agreement (the “Distribution Agreement”) with each of KeyBanc Capital Markets Inc., Robert W. Baird & Co. Incorporated, Barclays Capital Inc., Berenberg Capital Markets, LLC, BMO Capital Markets Corp., B. Riley Securities, Inc., Capital One Securities, Inc., Colliers Securities LLC, Citizens JMP Securities, LLC, Scotia Capital (USA) Inc., Truist Securities, Inc., Wells Fargo Securities, LLC, Barclays Bank PLC, Bank of Montreal, The Bank of Nova Scotia, Truist Bank and Wells Fargo Bank, National Association (and, in certain cases, their respective affiliates) in their capacity as Sales Agents, as Forward Sellers and/or as Forward Purchasers, in each case as described below, relating to (i) the issuance and sale by the Company to or through the Sales Agents, from time to time, of shares of the Company’s common stock (the “Issuance Shares”), and (ii) the sale by the Forward Sellers, as agents on be”
LYBLyondellBasell Industries N.V.
LyondellBasell Industries N.V. entered into Indenture with Wells Fargo Bank, National Association; Computershare Trust Company, N.A.; The Bank of New York Mellon Trust Company, N.A. valued at $750 million (effective 2019-10-10).
“On February 28, 2024, LyondellBasell Industries N.V. (the “Company”) and its wholly owned subsidiary, LYB International Finance III, LLC (the “Issuer”), completed the underwritten public offering and sale by the Issuer of $750 million aggregate principal amount of 5.500% Guaranteed Notes due 2034 (the “Notes”).”
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. amended Amendment No. 2 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement with Ajinomoto Althea, Inc. dba Ajinmoto Bio-Pharma Services (effective 2024-02-26).
“On February 26, 2024, Revance Therapeutics, Inc. (the “Company”) and Ajinomoto Althea, Inc. dba Ajinmoto Bio-Pharma Services, a contract development and manufacturing organization (“ABPS”), entered into Amendment No. 2 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement (the “Amendment”)”
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. entered into Sales Agreement with Cowen and Company, LLC valued at up to $100,000,000 (effective 2024-02-28).
“On February 28, 2024, Mersana Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a Sales Agreement (the “Sales Agreement”) with Cowen and Company, LLC as agent (“TD Cowen”) pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share, having an aggregate offering price of up to $100,000,000”
SNWVSANUWAVE Health, Inc.
SANUWAVE Health, Inc. amended Agreement and Plan of Merger Amendment Number One with SEP Acquisition Corp. valued at Outside Date extended from February 28, 2024 to April 30, 2024 (effective 2024-02-27).
“On February 27, 2024, the Company and SEPA entered into that certain Amendment Number One (the “Amendment”) to the Merger Agreement.”
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. terminated ATM Agreement with H.C. Wainwright & Co., LLC (effective 2024-02-26).
“On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C. Wainwright & Co., LLC (the “ATM Agreement”), establishing an at-the-market equity distribution program for the offer and sale from time to time shares of the Company’s common stock, par value $0.0001.”
BNGOBionano Genomics, Inc.
Bionano Genomics, Inc. entered into Amendment with High Trail Special Situations LLC (effective 2024-02-27).
“Concurrent with the entry into the Letter Agreement, the Company and the Purchaser entered into an Amendment to Initial Registered Note (the “Amendment”), among other things, to (i) reduce the minimum liquidity covenant under the Initial Registered Note”
BNGOBionano Genomics, Inc.
Bionano Genomics, Inc. entered into Letter Agreement with High Trail Special Situations LLC valued at total redemption payment of $19,550,000 (effective 2024-02-27).
“On February 27, 2024, the Company entered into a letter agreement (the “Letter Agreement”) with the Purchaser to (i) redeem (a) the entire outstanding principal amount under the Initial Private Placement Note of $17,000,000 from the Purchaser at a redemption price of 115% for a total redemption payment of $19,550,000”
First Trinity Financial CORP
First Trinity Financial CORP terminated Share Acquisition Agreement with MTCP LLC valued at Termination of Share Acquisition Agreement (effective 2024-02-26).
“On February 23, 2024, the Board of Directors of First Trinity Financial Corporation (the “Company”) unanimously voted to terminate the Share Acquisition Agreement dated April 24, 2023 (the “Agreement”) among the Company, MTCP LLC, a Florida limited liability company (the “Buyer”) and Brickell L&A Holdings LLC, a Delaware limited liability company wholly owned by the Buyer, pursuant to provisions of an amendment to the Agreement giving the Company the right to terminate the Agreement.”
SMCISuper Micro Computer, Inc.
Super Micro Computer, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $1.725 billion (effective 2024-02-27).
“On February 27, 2024, Super Micro Computer, Inc. (the “ Company ,” “ we ,” “ us ” or “ our ”) completed its previously announced sale of $1.725 billion in aggregate principal amount of 0.00% Convertible Senior Notes due 2029 (the “ Convertible Notes ”), including $225.0 million in aggregate principal amount of 0.00% Convertible Senior Notes due 2029 purchased pursuant to the exercise by the initial purchasers of the Convertible Notes (the “ Initial Purchasers ”) of the option (the “ Notes Option ”) to purchase additional Convertible Notes, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “ Securities Act ”). The Convertible Notes were issued under an indenture, dated as of February 27, 2024, (the “ Indenture ”) between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”).”
AAPADVANCE AUTO PARTS INC
ADVANCE AUTO PARTS INC amended Amendment No. 4 to the Credit Agreement dated November 9, 2021 with Bank of America, N.A., as administrative agent (effective 2024-02-26).
“On February 26, 2024, we entered into Amendment No. 4 to the Credit Agreement dated November 9, 2021, with Advance Auto Parts, Inc., as Borrower, Advance Stores Company, Incorporated, as a Guarantor, the lenders party thereto, and Bank of America, N.A., as administrative agent (the "2021 Credit Agreement")”
DELTA APPAREL, INC
DELTA APPAREL, INC entered into a asset purchase valued at $23.5 million (effective 2024-02-26).
“On February 26, 2024, Delta Apparel, Inc. (the “Company”) entered into an agreement providing for the sale and long-term leaseback of its approximately 35-acre campus in Fayetteville, North Carolina containing approximately 550,000 square feet of industrial space utilized across the Company’s various business units for manufacturing, decoration, distribution and other activities.”
WRLDWORLD ACCEPTANCE CORP
WORLD ACCEPTANCE CORP amended Twelfth Amendment with Wells Fargo Bank, National Association, as Administrative Agent and Collateral Agent (effective 2024-02-28).
“On February 28 th , 2024, World Acceptance Corporation (the “Company”) entered into the Twelfth Amendment to its Amended and Restated Revolving Credit Agreement (the “Twelfth Amendment”), among the Company, the lenders named therein, and Wells Fargo Bank, National Association, as Administrative Agent and Collateral Agent.”
CRVOCervoMed Inc.
CervoMed Inc. amended Amendment with The Joshua S. Boger 2021 Trust DTD 12/09/2021 (effective 2024-02-26).
“☐ 1 Item 1.01 Entry into a Material Definitive Agreement Amendment to Pre-Funded Warrant As previously disclosed, on August 16, 2023, CervoMed Inc.”
NovAccess Global Inc.
NovAccess Global Inc. entered into securities purchase agreement with AJB Capital Investments, LLC valued at $100,000 (effective 2024-02-27).
“On February 27, 2024, NovAccess Global Inc. (“NovAccess” or the “company”) entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of up to $100,000 (the “note”) to AJB pursuant to the SPA.”
BJRIBJs RESTAURANTS INC
BJs RESTAURANTS INC entered into Cooperation Agreement with Fund 1 Investments, LLC (effective 2024-02-28).
“On February 28, 2024, BJ’s Restaurants, Inc., a California corporation (the “ Company ”), announced its entry into a cooperation agreement (the “ Cooperation Agreement ”) with Fund 1 Investments, LLC (with its affiliates, “ Fund ”).”
BSXBOSTON SCIENTIFIC CORP
BOSTON SCIENTIFIC CORP entered into Underwriting Agreement with the several underwriters named in the Underwriting Agreement valued at €2,000,000,000 aggregate principal amount of its senior notes (effective 2024-02-22).
“On February 22, 2024, Boston Scientific Corporation (the “Company”), as guarantor, and American Medical Systems Europe B.V. (“AMS Europe”), its wholly owned finance subsidiary, as issuer, entered into an Underwriting Agreement, (as supplemented by the Terms Agreement, also dated February 22, 2024, the “Underwriting Agreement”), among the Company, AMS Europe and the several underwriters named in the Underwriting Agreement (the “Underwriters”), in connection with AMS Europe’s previously announced pricing of €2,000,000,000 aggregate principal amount of its senior notes.”
OSGOCTAVE SPECIALTY GROUP INC
OCTAVE SPECIALTY GROUP INC entered into Stipulation and Order with Wisconsin Office of the Commissioner of Insurance (effective 2024-02-22).
“Effective February 22, 2024, Ambac Financial Group, Inc. (“Ambac”) and Ambac Assurance Corporation (“AAC”) entered into a Stipulation and Order (the "Stipulation and Order") with the Wisconsin Office of the Commissioner of Insurance (“OCI”), which supersedes the Stipulation and Order that became effective on February 12, 2018, as amended (the “2018 Stipulation and Order”).”
AMERICAN HONDA FINANCE CORP
AMERICAN HONDA FINANCE CORP amended Second Amendment (effective 2024-02-23).
“Effective February 23, 2024, American Honda Finance Corporation (“AHFC”), amended (the “Second Amendment”) its $3,500,000,000 364-Day Credit Agreement”
ICCCIMMUCELL CORP /DE/
IMMUCELL CORP /DE/ amended Allonge to and Amendment of Line of Credit with Gorham Savings Bank valued at $1 million line of credit extended through September 11, 2025 (effective 2024-02-22).
“On February 22, 2024, ImmuCell Corporation (the “Company”) entered into an Allonge to and Amendment of Line of Credit (the “Allonge”) between the Company and Gorham Savings Bank (GSB) pursuant to which the Company’s $1 million line of credit with GSB was extended through September 11, 2025.”
FISVFISERV INC
FISERV INC entered into Underwriting Agreement with J.P. Morgan Securities LLC, TD Securities (USA) LLC and U.S. Bancorp Investments, Inc. valued at $750,000,000 aggregate principal amount of the Company’s 5.150% Senior Notes due 2027, $500,000,000 (effective 2024-02-26).
“On February 26, 2024, Fiserv, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, TD Securities (USA) LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters listed therein (the “Underwriters”), pursuant to which the Company agreed to sell, and the Underwriters agreed to purchase, subject to the terms and conditions set forth therein, $750,000,000 aggregate principal amount of the Company’s 5.150% Senior Notes due 2027 (the “2027 Notes”), $500,000,000 aggregate principal amount of the Company’s 5.350% Senior Notes due 2031 (the “2031 Notes”) and $750,000,000 aggregate principal amount of the Company’s 5.450% Senior Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes and the 2031 Notes, the “Notes”), in a public offering (the “Offering”).”
STAR EQUITY HOLDINGS, INC.
STAR EQUITY HOLDINGS, INC. terminated Purchase and Sale Agreement with Leaseback with SP Capital Partners LLC valued at Purchase and Sale Agreement with Leaseback cancelled due to Buyer's failure to obtain financing (effective 2024-02-22).
“The closing of the Sale and Leaseback Transaction was subject to the satisfaction of certain customary closing conditions and contingencies for transactions of this type. Such contingencies included the Buyer’s ability to obtain appropriate financing. Buyer’s failure to meet such conditions resulted in a cancellation of the Purchase Agreement on February 22, 2024.”
CENTERPOINT ENERGY HOUSTON ELECTRIC LLC
CENTERPOINT ENERGY HOUSTON ELECTRIC LLC entered into Underwriting Agreement with Barclays Capital Inc., BMO Capital Markets Corp., Citigroup Global Markets Inc., and TD Securities (USA) LLC, as representatives of the several Underwriters valued at $400,000,000 aggregate principal amount (effective 2024-02-26).
“On February 26, 2024, CenterPoint Energy Houston Electric, LLC (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., BMO Capital Markets Corp., Citigroup Global Markets Inc., and TD Securities (USA) LLC, as representatives of the several Underwriters named in Schedule I to the Underwriting Agreement (the “Underwriters”), relating to the underwritten public offering of $400,000,000 aggregate principal amount of the Company’s 5.15% General Mortgage Bonds, Series AN, due 2034”
PSNPARSONS CORP
PARSONS CORP entered into Purchase Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC valued at $700.0 million aggregate principal amount of its 2.625% Convertible Senior Notes due 2029 (effective 2024-02-21).
“On February 21, 2024, the Company entered into a purchase agreement (the “ Purchase Agreement ”) with BofA Securities, Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC as representatives of the several initial purchasers named therein (collectively, the “Initial Purchasers”), pursuant to which the Company agreed to issue and sell $700.0 million aggregate principal amount of its 2.625% Convertible Senior Notes due 2029”
PSNPARSONS CORP
PARSONS CORP entered into Indenture with U.S. Bank Trust Company, National Association (effective 2024-02-26).
“On February 26, 2024, the Company entered into an indenture (the “ Indenture ”) governing the terms of the Notes, by and between the Company and U.S. Bank Trust Company, National Association, as trustee”
AESIAtlas Energy Solutions Inc.
Atlas Energy Solutions Inc. entered into Agreement and Plan of Merger with Hi-Crush Inc., certain stockholders, and others (effective 2024-02-26).
“On February 26, 2024, Atlas Energy Solutions Inc., a Delaware corporation (the “ Company ” or “ Atlas ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Atlas Sand Company, LLC, a Delaware limited liability company (“ Purchaser ”), Wyatt Merger Sub 1 Inc., a Delaware corporation and direct, wholly-owned Subsidiary of Purchaser (“ Merger Sub 1 ”), Wyatt Merger Sub 2, LLC, a Delaware limited liability company and direct, wholly-owned Subsidiary of Purchaser (“ Merger Sub 2 ”), Hi-Crush Inc., a Delaware corporation (“ Hi-Crush ”), each stockholder that has executed the Merger Agreement or a joinder thereto (each a “ Hi-Crush Stockholder ” and, collectively, the “ Hi-Crush Stockholders ”), (f) Clearlake Capital Partners V Finance, L.P., solely in its capacity as the Hi-Crush Stockholders’ representative (the “ Hi-Crush Stockholders’ Representative ”) and (g) HC Minerals Inc., a Delaware corporation (collectively, the “ Parties ”), pursuant”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.